Location: Nijmegen
Synced from ClinicalTrials.gov · August 08, 2026
Clinical studies recruiting near Nijmegen
Studies with at least one listed site matching this
location on the public registry. Each page explains the study in plain
language, with locations and study-team contacts.
Clinicians: generate a
printable list for your patient →
🔍 Search another city or condition
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract Phase 3 · Radboudumc · Eli Lilly and Company · NCT07218380 Single-dose Preoperative Partial Breast Irradiation in Low-risk Breast Cancer Patients NA · Canisius Wilhelmina Ziekenhuis · Amsterdam UMC, location VUmc · NCT05350722 This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W Phase 3 · Canisius-Wilhelmina Ziekenhuis · Pfizer · NCT07028853 Early Longitudinal Imaging in the Parkinson's Progressive Marker Initiative (PPMI) Using (18F)AV-133 (PPMI AV-133 Prodro Phase 2 · Radboud University · Michael J. Fox Foundation for Parkinson's Research · NCT07265596 UCAN CAN-DU: Canada-Netherlands Personalized Medicine Network in Childhood Arthritis and Rheumatic Disease Phase N/A · Amalia Children's Hospital, Radboudumc · The Hospital for Sick Children · NCT06560606 Ten Year Follow-up in FSHD: the FOCUS 3 Study Phase N/A · Radboudumc · Radboud University Medical Center · NCT06911190 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov Phase 3 · Radboud Universitair Medisch Centrum · Amgen · NCT07037433 REDO-JAK: Dose Reduction of Janus Kinase Inhibitors in Patients With Inflammatory Rheumatic Diseases Phase 4 · Sint Maartenskliniek Nijmegen · Sint Maartenskliniek · NCT07160231 A Study of Inlexisertib (DCC-3116) in Combination With Anticancer Therapies in Participants With Advanced Malignancies Phase 1/Phase 2 · Radboudumc · Deciphera Pharmaceuticals, LLC · NCT05957367 A Safety and Pharmacokinetics Trial of VO659 in SCA1, SCA3 and HD Phase 1/Phase 2 · Radbout University Medical Centre · Vico Therapeutics B. V. · NCT05822908 A Prospective Randomised Study of Treatment Selection Based on Epigenetic Markers Versus Standard of Care Treatment Sele NA · Radboudumc · Alimentiv Inc. · NCT07363044 A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease Phase 3 · Radboud Umcn · Janssen Research & Development, LLC · NCT07499232 Use of Physiology to Evaluate Procedural Result After PCI CTO NA · Radboud UMC · Isala · NCT04780971 An European Multi-centre Cohort Study for Unravelling Pharmacokinetic and Genetic Factors Underlying Post-ERCP Pancreati Phase N/A · RadboudUMC · Radboud University Medical Center · NCT05267379 Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcera Phase 3 · Radboudumc · Eli Lilly and Company · NCT06937086 Study on Prognosis of Acutely Ruptured Intracranial Aneurysms Phase N/A · Radboudumc · Haaglanden Medical Centre · NCT05851989 [18F]F-FAPI PET-CT to Identify Carcinoma of Unknown Primary Origin NA · Radboud UMC · Erasmus Medical Center · NCT06644716 Alpelisib in Pediatric and Adult Patients With Lymphatic Malformations Associated With a PIK3CA Mutation. Phase 2/Phase 3 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT05948943 Vegetarian Diet and Innate Immunity in Patients With Myocardial Infarction and in Healthy Volunteers (FRESH-MI Study) NA · Radboudumc · Radboud University Medical Center · NCT06209723 A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic So Phase 1/Phase 2 · Radboudumc Nijmegen · Daiichi Sankyo · NCT06330064 Phase II Study of Oral Metformin for Intravesical Treatment of Non-muscle-invasive Bladder Cancer Phase 2 · RadboudUMC · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC · NCT03379909 Effectiveness of Focal Therapy in Men With Prostate Cancer NA · Radboud University Medical Centre · Radboud University Medical Center · NCT06223295 Minimal Invasive Axillary Staging and Treatment After Neoadjuvant Systemic Therapy in Node Positive Breast Cancer Phase N/A · Canisius Wilhelmina Hospital · Maastricht University Medical Center · NCT04486495 A Study With CIT-013 in RA Patients Phase 2 · NL-03 · Citryll BV · NCT06567470 Dutch-Depression Outcome Trial Comparing 5 Day Multi Daily Neuronavigated Theta Burst Sessions With 6 Weeks rTMS NA · Radboud UMC · Amsterdam UMC, location VUmc · NCT05900271 Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers Phase 1 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT06562192 A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung C Phase 3 · Radboudumc ( Site 1706) · Merck Sharp & Dohme LLC · NCT06623422 A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy Phase 3 · Radboud Universitair Medisch Centrum · Takeda · NCT06963827 Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesop Phase 3 · Radboudumc · Daiichi Sankyo · NCT06731478 Phase II Randomised Controlled Trial of Patient-specific Adaptive vs. Continuous Abiraterone or eNZalutamide in mCRPC Phase 2 · Radboud Univeristy Medical Centre · Leiden University Medical Center · NCT05393791
Look up another city
Look up another condition